Date: 03-Sep-2019

Ajinomoto Bio-Pharma buys Indian API plant from JV partner

Ajinomoto Bio-Pharma Services is taking full control of an API manufacturing facility in India as the CDMO continues to bulk up in a market that favors companies that can do it all. Ajinomoto Bio-Pharma today announced it is buying the 50% share of the joint venture still owned by Indian partner Granules OmniChem (GOC). The JV was first established in 2011 and operates a plant in Visakhapatnam that manufactures small-molecule intermediates and active pharmaceutical ingredients (APIs). Terms of the deal were not disclosed.